The recent discoveries about the bone mechanisms of newly established OI types XIX, XX, XXI and XXII have fully validated recessive mutations in TENT5A, MESD, KDELR2 and CCDC134, respectively, as OI-causative within the umbrella of type I collagen-related gene defects. The gene discussed is KDELR2; the disease is osteogenesis imperfecta.